Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Harvard Business School
Boehringer Ingelheim

Generated: June 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021952

« Back to Dashboard

NDA 021952 describes CLARITIN, which is a drug marketed by Bayer Healthcare Llc and is included in seven NDAs. It is available from five suppliers. There is one patent protecting this drug. Additional details are available on the CLARITIN profile page.

The generic ingredient in CLARITIN is loratadine; pseudoephedrine sulfate. There are thirty-nine drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the loratadine; pseudoephedrine sulfate profile page.
Summary for 021952
Applicant:Bayer Healthcare Llc
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 021952
Suppliers and Packaging for NDA: 021952
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLARITIN loratadine CAPSULE;ORAL 021952 NDA Bayer HealthCare LLC. 11523-7200 N 11523-7200-1
CLARITIN loratadine CAPSULE;ORAL 021952 NDA Bayer HealthCare LLC. 11523-7200 N 11523-7200-6

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:CAPSULE;ORALStrength10MG
Approval Date:Jun 16, 2008TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.